Zobrazeno 1 - 10
of 27
pro vyhledávání: '"wf_300"'
There is inconclusive evidence on the association between ambient air pollution and pulmonary tuberculosis (PTB) incidence, tuberculosis-related hospital admission and mortality. This review aimed to assess the extent to which selected air pollutants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::046879f5b87d7fe2cddfd010fcdf87c6
https://archive.lstmed.ac.uk/20666/1/Scien_Rep_s41598-022-15443-9.pdf
https://archive.lstmed.ac.uk/20666/1/Scien_Rep_s41598-022-15443-9.pdf
Autor:
Grant Theron, Karen R Steingart, Geraint Davies, Margaretha de Vos, Samantha Pillay, Samuel G Schumacher, Rob Warren, Marty Chaplin
Publikováno v:
Cochrane Database of Systematic Reviews
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
Cochrane Database Syst Rev
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
Cochrane Database Syst Rev
Background\ud The World Health Organization (WHO) End TB Strategy stresses universal access to drug susceptibility testing (DST). DST determines whether Mycobacterium tuberculosis bacteria are susceptible or resistant to drugs. Xpert MTB/XDR is a rap
Autor:
Geraint Davies, Andrew D. McCallum, Laura Else, Rose D Malamba, Stephen B. Gordon, Irene Sheha, Madalitso Chasweka, Jamilah Meghji, Henry C. Mwandumba, Alex Chitani, Aaron P Chirambo, Henry Pertinez, Derek J. Sloan, Saye Khoo, Sujan Dilly-Penchala
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
CLINICAL INFECTIOUS DISEASES
CLINICAL INFECTIOUS DISEASES
Background Further work is required to understand the intrapulmonary pharmacokinetics of first-line anti-tuberculosis drugs. This study aimed to describe the plasma and intrapulmonary pharmacokinetics of rifampicin, isoniazid, pyrazinamide, and etham
Autor:
Marahatta, Sujan Babu, Yadav, Rajesh Kumar, Baral, Sushila, Aryal, Neeta, Paudel, Srijana, Shah, Naveen Prakash, Yadav, Punita, Gurung, Suman Chandra, Khatri, Elina
Treatment compliance is an important aspect for tuberculosis prevention and control. Poor compliance to treatment can lead to the development of drug-resistant tuberculosis. The aim of this study was to explore the factors affecting treatment complia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::a994a0ce13dce40dce83e00da767a5d2
https://archive.lstmed.ac.uk/20013/1/J_Nepal_HRC_19_52_450-459.pdf
https://archive.lstmed.ac.uk/20013/1/J_Nepal_HRC_19_52_450-459.pdf
Autor:
Alexander S. Pym, Khadija Khan, Timothy R. Sterling, Sashen Moodley, Alison D. Grant, Mahomed-Yunus S. Moosa, Farina Karim, Al Leslie, Naomi F Walker, Yuri van der Heijden, Matilda Mazibuko, Paul T. Elkington
Current methods for tuberculosis treatment monitoring are suboptimal. We evaluated plasma matrix metalloproteinase (MMP) and procollagen III N-terminal propeptide concentrations before and during tuberculosis treatment as biomarkers. Plasma MMP-1, MM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::befa10a3465f82a6e124f118f27e1e9f
https://doi.org/10.1101/2021.11.15.21265734
https://doi.org/10.1101/2021.11.15.21265734
Autor:
Fatima Chitimbe, Jamilah Meghji, Kevin Mortimer, Stephen Bertel Squire, Stephen B. Gordon, Jamie Rylance, Rachael Thomson, Jason Madan, Elizabeth L. Corbett, Stefanie Gregorius, Ndaziona Pk Banda
Publikováno v:
Thorax
BackgroundMitigating the socioeconomic impact of tuberculosis (TB) is key to the WHO End TB Strategy. However, little known about socioeconomic well-being beyond TB-treatment completion. In this mixed-methods study, we describe socioeconomic outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bfdd177bdeac98e808bdcb6bd2f82ef
Autor:
Nandini Dendukuri, Ian Schiller, Mikashmi Kohli, Adrienne E Shapiro, Karen R Steingart, David J. Horne, Jennifer M. Ross
Publikováno v:
Cochrane Database Syst Rev
Objectives\ud This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:\ud \ud To determine the accuracy of Xpert MTB/RIF and Xpert Ultra for screening for tuberculosis in adults irrespective of signs or symptoms of pulmon
Population-based Screening for Pulmonary Tuberculosis utilizing Community Health Workers in Ethiopia
Autor:
Mesay Hailu, Tsegaye Hailu, Yared Merid, Yimtubezinash Woldeamanuel Mulate, Abraham Aseffa, Daniel G. Datiko, Getnet Habtamu, Markos Abebe
Publikováno v:
International Journal of Infectious Diseases, Vol 89, Iss, Pp 122-127 (2019)
Objective: To evaluate the utility of a volunteer health development army in conducting population screening for active tuberculosis (TB) in a rural community in southern Ethiopia. Methods: A population-based cross-sectional survey was conducted in s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7094e9786d44e4a0c8c5c52311dff546
https://archive.lstmed.ac.uk/12918/1/1-s2.0-S1201971219304059-main.pdf
https://archive.lstmed.ac.uk/12918/1/1-s2.0-S1201971219304059-main.pdf
Autor:
Ali M. Al-Shangiti, Badriah Alotaibi, Alimuddin Zumla, Gamal Mohamed, Saber Yezli, Abdulhafiz M. Turkistani, Yara Yassin
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Mass gatherings pose a risk for tuberculosis (TB) transmission and reactivation of latent TB infection. The annual Hajj pilgrimage attracts 2 million pilgrims many from high TB-endemic countries. We evaluated the burden of undiagnosed active pulmonar
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
Autor:
Karen R Steingart, Deanna Tollefson, Jerry S Zifodya, David J. Horne, Samuel G Schumacher, Eleanor A Ochodo, Ian Schiller, Mikashmi Kohli, Madhukar Pai, Nandini Dendukuri
Publikováno v:
The Cochrane Database of Systematic Reviews
Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the newest version, are the only World Health Organization (WHO)‐recommended rapid tests that simultaneously detect tuberculosis and rifampicin resistance in persons wi